- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00010881
Oregon Center for Complementary and Alternative Medicine in Neurological Disorders
The mission of the Oregon Center for Complementary and Alternative Medicine in Neurological Disorders (ORCCAMIND) is to facilitate research and education on the effectiveness and mechanisms of action of complementary and alternative medicine (CAM) therapies in the treatment of neurological disorders. The integration of conventional medicine and CAM communities is critical for the success of ORCCAMIND. Thus, ORCCAMIND is composed of six institutions: Oregon Health Sciences University; National College of Naturopathic Medicine; Western States Chiropractic College; Oregon College of Oriental Medicine; the Linus Pauling Institute at Oregon State University; and the Portland Veterans Affairs Medical Center.
ORCCAMIND will initially focus on the use of CAM antioxidants and stress reduction as treatments for neurodegenerative and demyelinating diseases because many of these diseases have oxidative injury as a causative or contributory factor and several CAM approaches have direct or indirect anti-oxidant effects. Through the Career Development Program the Developmental Research Program and the activities of the Education and Information Core, we will also foster and promote research into other CAM approaches for neurologic diseases that extend beyond anti-oxidant therapies. ORCCAMIND will achieve its goals by carrying out 4 Research Projects and maintaining 4 Core facilities that integrate the research strengths of conventional medicine and CAM practitioners and researchers. ORCCAMIND draws its strength from the multi-institutional support and the quality of all its investigators. The investigators join ORCCCAMIND with extensive experience with clinical trials, patient care, externally funded basic and clinical neuroscience research, and training programs, including federally-funded training grants. ORCCAMIND is a bold initiative that integrates basic and clinical research scientists, conventional neurologists and CAM practitioners. It will promote the exploration of new areas of CAM research and lead research on CAM therapies for neurological disorders.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97201
- Oregon Health Sciences Univ./Neurology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- written informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
Collaborators and Investigators
Investigators
- Principal Investigator: Dr. Barry S. Oken, Oregon Health and Science University
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P50 AT000066-01M
- P50AT000066-01 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurological Disorders
-
University of LeedsThe Royal College of Surgeons of EnglandCompletedSurgery | Surgery--Complications | Outcome, Fatal | Neurological Disorder | Morality | Neurological Morbidity | Neurological Complication | Comorbidities and Coexisting Conditions | Neurological Diseases or Conditions | Neurological Procedural Complication
-
Wayne State UniversityCompletedNeurological DisordersUnited States
-
Damanhour UniversityMansoura UniversityCompletedNeurological Disorders
-
Pôle Saint HélierCompletedNeurological DisordersFrance
-
University of FloridaNational Science FoundationCompleted
-
Innodem NeurosciencesSuspendedNeurological DisordersCanada
-
University of FribourgInsel Gruppe AG, University Hospital BernRecruitingFunctional Neurological Symptom Disorder | Neurological Diseases or ConditionsSwitzerland
-
University College, LondonCompletedFunctional Neurological DisordersUnited Kingdom
-
University of ZurichRecruitingGait Analysis in Neurological DisordersSwitzerland
-
South West London and St George's Mental Health...Active, not recruitingFunctional Neurological Symptom DisorderUnited Kingdom
Clinical Trials on antioxidants
-
Roswell Park Cancer InstituteCompleted
-
University of BelgradeActive, not recruitingPeriodontitis | Systemic SclerosisSerbia
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompletedHypertension | Insulin Resistance | Oxidative Stress | Autonomic Imbalance
-
Laboratorios OrdesaPeruvian Clinical Research; Quantum ExperimentalCompletedMalnutrition | Cystic Fibrosis | Failure to ThriveSpain, Peru
-
ScienceBased HealthCompletedPrimary Open Angle GlaucomaUnited States
-
ART Fertility Clinics LLCNot yet recruitingInfertility | In Vitro Fertilization
-
University Hospital, RouenCompleted
-
University of ThessalyARGALASTI HEALTH CENTRECompletedChronic Obstructive Pulmonary DiseaseGreece
-
National Eye Institute (NEI)Bausch & Lomb IncorporatedCompletedMacular Degeneration | Cataract | Lens Opacities
-
Prince of Songkla UniversityAlcon ResearchCompletedCentral Serous ChorioretinopathyThailand